#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419934	Binding	Inhibition of YAP1 (unknown origin) assessed as disruption in YAP1/OCT4 interaction by ELISA	Homo sapiens	33	ALA4419178	single protein format	Patent Bioactivity Data
2.	ALA4419935	Binding	Inhibition of YAP1 (unknown origin) assessed as disruption in YAP1/OCT4 interaction at 5 uM by ELISA relative to control	Homo sapiens	11	ALA4419178	single protein format	Patent Bioactivity Data
3.	ALA4419937	Binding	Inhibition of YAP1 (unknown origin) assessed as disruption in YAP1/OCT4 interaction at 50 uM by cell based assay	Homo sapiens	16	ALA4419178	cell-based format	Patent Bioactivity Data
4.	ALA4419942	Binding	Inhibition of YAP1 in human NCI-H1650 cells assessed as disruption in YAP1/OCT4 interaction at 5 uM incubated for 72 hrs by immunoprecipitation-Westem blot assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
5.	ALA4419943	Binding	Inhibition of YAP1 in human A549 cells assessed as disruption in YAP1/OCT4 interaction at 5 uM incubated for 72 hrs by immunoprecipitation-Westem blot assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
6.	ALA4419957	Functional	Cytotoxicity in human NCI-H1650 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 72 hrs by MTT assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
7.	ALA4419958	Functional	Cytotoxicity in human A549 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 72 hrs by MTT assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
8.	ALA4419961	Binding	Inhibition of YAP1 in human NCI-H1650 cells assessed as reduction in Sox2 protein expression at 50 uM by luciferase reporter gene assay	Homo sapiens	1	ALA4419178	cell-based format	Patent Bioactivity Data
9.	ALA4419962	Functional	Inhibition of self-renewal capacity in stem-like side-population cells of human NCI-H1650 cells assessed as reduction in number of spheres at 50 uM incubated for 10 days by sphere formation assay relative to control	Homo sapiens	1	ALA4419178	cell-based format	Patent Bioactivity Data
10.	ALA4419965	Functional	Cytotoxicity in human NCI-H1703 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 96 hrs by MTT assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
11.	ALA4419966	Functional	Cytotoxicity in human NCI-H226 cells assessed as reduction in cell viability at 0.5 to 20 uM incubated for 96 hrs by MTT assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
12.	ALA4419973	Functional	Inhibition of self-renewal capacity in cisplatin insensitive stem-like side-population cells of human NCI-H1650 cells assessed as reduction in number of spheres at 2 uM incubated for 5 days after 7 days cisplatin exposure by sphere formation assay	Homo sapiens	2	ALA4419178	cell-based format	Patent Bioactivity Data
13.	ALA4419974	Functional	Inhibition of self-renewal capacity in methotrexate insensitive stem-like side-population cells of human NCI-H146 cells assessed as reduction in number of spheres at 2 uM incubated for 3 days after 7 days methotrexate exposure by sphere formation assay	Homo sapiens	6	ALA4419178	assay format	Patent Bioactivity Data
14.	ALA4419975	Functional	Cytotoxicity in erlotinib-resistant human HCC827 cells assessed as reduction in cell viability at 1 to 20 uM by MTT assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
15.	ALA4419976	Functional	Cytotoxicity in gefitinib resistant human PC9 cells assessed as reduction in cell viability at 1 to 20 uM by MTT assay	Homo sapiens	3	ALA4419178	cell-based format	Patent Bioactivity Data
16.	ALA4419977	Functional	Cytotoxicity in gefitinib and erlotinib resistant human NCI-H1975 cells assessed as reduction in cell viability at 1 to 10 uM incubated for 72 hrs by MTT assay	Homo sapiens	5	ALA4419178	cell-based format	Patent Bioactivity Data
17.	ALA4419978	Binding	Inhibition of YAP1 in human NCI-H1650 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method	Homo sapiens	5	ALA4419178	cell-based format	Patent Bioactivity Data
18.	ALA4419979	Binding	Inhibition of YAP1 in human NCI-H1703 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method	Homo sapiens	5	ALA4419178	cell-based format	Patent Bioactivity Data
19.	ALA4419980	Binding	Inhibition of YAP1 in human NCI-H146 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method	Homo sapiens	5	ALA4419178	cell-based format	Patent Bioactivity Data
20.	ALA4419981	ADME	Effect on expression of Oct4 mRNA expression in human NCI-H1650 cells at 5 to 10 uM incubated for 72 hrs by RT-PCR method	Homo sapiens	5	ALA4419178	cell-based format	Patent Bioactivity Data